Jinduicheng Molybdenum (601958) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Dec, 2025Executive summary
Revenue for the first three quarters of 2024 reached RMB 10.10 billion, up 14.06% year-over-year.
Q3 2024 revenue was RMB 3.50 billion, up 4.82% year-over-year.
Net profit attributable to shareholders for the first three quarters was RMB 2.19 billion, down 6.07% year-over-year.
Q3 net profit attributable to shareholders was RMB 688 million, down 18.49% year-over-year.
Profit decline attributed to lower product prices despite higher sales volume and cost controls.
Financial highlights
Basic and diluted EPS for the first three quarters was RMB 0.680, down 6.08% year-over-year.
Q3 basic and diluted EPS was RMB 0.213, down 18.70% year-over-year.
Total assets at period end were RMB 19.89 billion, up 8.76% from year-end 2023.
Shareholders' equity was RMB 16.28 billion, up 6.32% from year-end 2023.
Operating profit decreased 6.84% and total profit fell 6.43% year-over-year.
Key financial ratios and metrics
Weighted average ROE for the first three quarters was 13.68%, down 2.81 percentage points year-over-year.
Q3 weighted average ROE was 4.50%, down 1.79 percentage points year-over-year.
Net assets per share rose to RMB 5.05, up 6.32% from the start of the year.
Operating margin and net margin declined due to higher costs and lower non-recurring income.
Latest events from Jinduicheng Molybdenum
- Q3 net profit rose 31.42% year-over-year on higher product prices and effective cost control.601958
Q3 202515 Dec 2025 - Revenue up 17.55% but net profit down 3.18% due to weaker product prices.601958
H2 202415 Dec 2025 - Revenue up 19.66% and net profit up 0.95% year-over-year, with robust market position.601958
H1 202415 Dec 2025 - Revenue up 5.55%, net profit down 8.45% as raw material reserves and processing sales impact results.601958
H1 202515 Dec 2025 - Revenue and net profit rose year-over-year, but operating cash flow turned negative.601958
Q1 202510 Sep 2025